GHRP-6 (5mg x 10), Ipamorelin (5mg x 10)
GHRP-6 and Ipamorelin are synthetic research peptides that are frequently used together in experimental models to study the regulation of the growth hormone axis and the signaling of pituitary receptors.
GHRP-6 and Ipamorelin are synthetic research peptides that are frequently used together in experimental models to study the regulation of the growth hormone axis and the signaling of pituitary receptors.
Browse nearby entries from the full catalog, starting with Vial Kits.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantGHRP-6 and Ipamorelin are synthetic research peptides that are frequently used together in experimental models to study the regulation of the growth hormone axis and the signaling of pituitary receptors. GHRP-6 is a hexapeptide growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R1a) and participates in Gq-/PLC-dependent calcium signaling pathways involved in GH release and in hypothalamic–pituitary feedback mechanisms. Ipamorelin is a selective pentapeptide GHS-R1a agonist that promotes GH secretion through calcium-mediated signaling, while showing minimal interactions with other pituitary-hormonal systems in preclinical studies. The combined use of GHRP-6 and Ipamorelin enables the investigation of complementary GHS-R1a signaling dynamics, receptor pharmacology, and modulation of somatotropic signaling pathways.
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.